SC 13G/A: Sana Biotechnology, Inc.
Ticker: SANA · Form: SC 13G/A · Filed: 2024-04-03T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Sana Biotechnology, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000315066-24-001687 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000315066-24-001687 Filing Date 2024-04-03 Accepted 2024-04-03 09:52:22 Documents 1 Document Format Files Seq Description Document Type Size 1 filing.txt SC 13G/A 5949 Complete submission text file 0000315066-24-001687.txt 7628 Mailing Address 245 SUMMER STREET BOSTON MA 02210 Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339 FMR LLC (Filed by) CIK : 0000315066 (see all company filings) EIN. : 043532603 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 0000 Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914 Sana Biotechnology, Inc. (Subject) CIK : 0001770121 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-92124 | Film No.: 24817144 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)